Skip to Content

Gen Ilac Ve Saglik Urunleri Sanayi ve Ticaret AS GENIL

Morningstar Rating
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

GENIL is trading at a 496% premium.
Price
TRY 65.27
Fair Value
TRY 49.68
Uncertainty
High
1-Star Price
TRY 358.36
5-Star Price
TRY 47.74
Economic Moat
Nbm
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if GENIL is a good fit for your portfolio.

Trading Information

Previous Close Price
Day Range
52-Week Range
Bid/Ask
/
Market Cap
Volume/Avg
/

Key Statistics

Price/Earnings (Normalized)
48.80
Price/Sales
2.41
Dividend Yield (Trailing)
0.57%
Dividend Yield (Forward)
0.57%
Total Yield
0.57%

Company Profile

Gen Ilac Ve Saglik Urunleri Sanayi ve Ticaret AS is a specialty pharmaceuticals company in Turkey. Its locally manufactured products include Cajex, Contra-K, Epamor, Genkort, Ilopera, among others, while imported products include AvonexPEN, Plegridy, Tecfidera, Regen-D among others.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Growth
Total Number of Employees
622

Comparables

Valuation

Metric
GENIL
PAGYO
GLCVY
Price/Earnings (Normalized)
48.804.76
Price/Book Value
4.070.53
Price/Sales
2.418.83
Price/Cash Flow
33.6513.39
Price/Earnings
GENIL
PAGYO
GLCVY

Financial Strength

Metric
GENIL
PAGYO
GLCVY
Quick Ratio
0.861.087.34
Current Ratio
1.461.147.90
Interest Coverage
1.3231.24
Quick Ratio
GENIL
PAGYO
GLCVY

Profitability

Metric
GENIL
PAGYO
GLCVY
Return on Assets (Normalized)
5.97%51.97%24.85%
Return on Equity (Normalized)
8.79%54.64%40.95%
Return on Invested Capital (Normalized)
8.88%54.58%29.56%
Return on Assets
GENIL
PAGYO
GLCVY
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Zoetis Inc Class A
ZTS
JlqwncylSygk$80.1 Bil
Merck KGaA ADR
MKKGY
VpkmwfxldSbthg$70.7 Bil
Haleon PLC ADR
HLN
VzcdlknygNqltv$37.8 Bil
Teva Pharmaceutical Industries Ltd ADR
TEVA
PnypkzhZlxm$18.9 Bil
Dr Reddy's Laboratories Ltd ADR
RDY
LbrntfxnhPhbrl$12.8 Bil
Viatris Inc
VTRS
BddqyszcYjr$12.4 Bil
Catalent Inc
CTLT
PhwpjrsfYtmlfp$10.2 Bil
Perrigo Co PLC
PRGO
RtldjssvHqsz$3.6 Bil
Prestige Consumer Healthcare Inc
PBH
WfcxgfmdYbkljw$3.4 Bil
Curaleaf Holdings Inc
CURLF
VxmxhxhGjgnl$2.9 Bil

Sponsor Center